Abstracts tagged "Shoulder Pain and ultrasonography"

Abstract Number: 125 • 2013 ACR/ARHP Annual Meeting
Correlation Of Findings In Clinical and High Resolution Ultrasonography Examinations Of The Painful Shoulder
Raphael Micheroli¹, Diego Kyburz², Adrian Ciurea³, Beat Dubs⁴, Martin Toniolo², Samuel Bisig⁵ and Giorgio Tamborrini⁶, ¹Faculty of Medicine, University of Zurich, Zurich, Switzerland, ²Department of Rheumatology, University Hospital of Zurich, Zurich, Switzerland, ³Center of Experimental Rheumatology, University Hospital Zurich, Zurich Schlieren, Switzerland, ⁴Sonography Institute Bethanien Zurich, Zurich, Switzerland, ⁵Swiss Federal Institute of Technology Zurich, Zurich, Switzerland, ⁶Department of Rheumatology and Musculoskeletal Ultrasound, Bethesda Hospital Basel, Basel, Switzerland
Background/Purpose: High resolution ultrasonography (HRUS) is a non-painful and non-invasive imaging technique which is increasingly used for evaluating patients with musculoskeletal disorders. In particular, HRUS…
Abstract Number: 232 • 2013 ACR/ARHP Annual Meeting
Can Musculoskeletal Ultrasonography Examination (MSUS) Predict Outcome In Shoulder Impingement Syndrome (SIS)? A Prospective Blinded Study
Mumtaz Khan¹, Karen McCreesh², Aamir Saeed¹, Tomas Ahern³ and Alexander D. Fraser⁴, ¹Rheumatology, Limerick University Hospital, Limerick, Ireland, ²Physiotherapy, University of Limerick, Limerick, Ireland, ³St. Vincent's University Hospital, Dublin, Ireland, ⁴Rheumatology, Limerick Univeristy Hospital, Limerick, Ireland
Background/Purpose: Steroid injection and active physiotherapy are the two standard conservative therapies used to treat SIS and the outcome from these two treatments varies depending…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].